Alembic Pharmaceuticals consolidated net profit declines 85.86% in the March 2022 quarter

2 May 2022 , 04:33 PM

Net profit of Alembic Pharmaceuticals declined 85.86% to Rs 35.46 crore in the quarter ended March 2022 as against Rs 250.70 crore during the previous quarter ended March 2021. Sales rose 10.57% to Rs 1415.74 crore in the quarter ended March 2022 as against Rs 1280.39 crore during the previous quarter ended March 2021.

For the full year,net profit declined 53.68% to Rs 545.68 crore in the year ended March 2022 as against Rs 1178.11 crore during the previous year ended March 2021. Sales declined 1.62% to Rs 5305.79 crore in the year ended March 2022 as against Rs 5393.13 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	1415.74	1280.39	11	5305.79	5393.13	-2
OPM %	11.31	25.01	–	16.48	27.45	–
PBDT	163.67	343.08	-52	906.89	1551.55	-42
PBT	40.59	291.86	-86	620.11	1368.08	-55
NP	35.46	250.70	-86	545.68	1178.11	-54

Powered by Capital Market – Live News